Presentations 2011
6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Rome 2011
Oral
1 Risk of progression to AIDS or death in relation to CD4 cell levels in HIV-infected patients with sustained viral response to cART. Heiner C. Bucher on behalf of the OI working group of COHERE. presentation (175 KB)
18th Conference on Retroviruses and Opportunistic Infections, Boston, February 2011
1 HCV Treatment and CD4 Cell Count Decline in HIV/HCV Co-infected Patients: European Cohort Collaboration. C Smit, A d'Arminio, F de Wolf, M Puoti, F Dabis on behalf of the HCV working group of COHERE. poster (99 KB)
Presentations 2010
XVIII International AIDS Conference Vienna
Orals
1 Impact of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy. L Wittkop on behalf of the EuroCoord-CHAIN joint project team.
2 PLATO II: Triple class virologic failure (TCVF) in HIV-infected children. Karina Butler on behalf of the PLATO II Project Team of COHERE
Presentations 2009
EACS Conference 11-14 November 2009 Cologne
Oral
1 CD4 count, viral suppression, prophylaxis and the risk of primary pneumocystis pneumonia in the cart era - the Collaboration of Observational HIV Epidemiological Research Europe (COHERE). Amanda Mocroft, for the Opportunistic Infections Working Group.
2 Mortality rates of elderly HIV-infected adults treated with antiretroviral are closer to general population than in younger patients. Charlotte Lewden on behalf of COHERE.
Posters
1 Presence of drug resistance during the course of treatment in patients who developed virological failure to the three original classes of antiretroviral drug. Frank de Wolf on behalf of COHERE.
2 Viral load outcome after virologic failure of the three original antiretroviral drug classes in 2000-2007. Dominique Costagliola on behalf of COHERE.
3 HIV-related Hodgkin lymphoma in the era of HAART: incidence and survival in a European mulit-cohort study. Julia Bohlius on behalf of COHERE.
16th Conference on Retroviruses and Opportunistic Infections, Montreal, February 2009
Posters
1 Risk of extensive triple class virologic failure of the three original antiretroviral drug classes among people followed from therapy initiation with NNRTI or ritonavir-boosted PI regimens. R Lodwick on behalf of the PLATO II project team of COHERE.
Poster 159 KB
2 Impact of cART on Incidence and Prognosis of HIV-1-associated Non-Hodgkin-Lymphoma - European Multi-Cohort Study. J Bohlius, M Egger, on behalf of the COHERE study group.
Poster 517 KB
Presentations 2007
14th Conference on Retroviruses and Opportunistic Infections, Los Angeles, February 2007
Poster
1 Response to combination antiretroviral therapy (cART): variation by age.
CA Sabin for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study
Poster 528 as pdf file 216 KB
Updated: 25 Jul 2011